The Cancer Service Line (CSL) and the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center (ACC) are delighted to announce the selection of the 2022 Access Accelerator project.
Over the next six months, this team will work closely with innovation and operational support from CSL and PC3I to design and test an intervention to improve patient access to hematologic oncology care. They will also receive mentorship and advising from a broad group of stakeholders representing both inpatient and outpatient hematologic care as well as health system operations and leadership. At the conclusion of the pilot, the project team will present its progress and findings and identify opportunities for scale.
A $3.5 million grant from the National Cancer Institute (NCI) will help clinicians provide better care to women with cervical cancer in the nation of Botswana.
Through the Innovation Accelerator, the Cancer Service Line & PC3I invite applications for initiatives that create and test innovative solutions to address challenges in cancer care access.
PC3I is pleased to share our 2021-2022 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.